Octant Bio

About:

Octant Bio is a developer of synthetic technology used to improve health and treat disease.

Website: https://www.octant.bio

Twitter/X: OctantBio

Top Investors: Andreessen Horowitz, 8VC, Bristol-Myers Squibb, Catalio Capital Management, What If Ventures

Description:

Octant Bio is a developer of synthetic technology used to improve health and treat disease. Its technology uses synthetic biology, genome engineering, next-generation sequencing, and computational tools to simultaneously measure the activity of thousands of receptor pathways in human cells that enable scientists to apply machine learning methods to engineer small molecules that interact with multiple receptors and unlock a new potential to treat complex diseases.

Total Funding Amount:

$115M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Los Angeles, California, United States

Founded Date:

2017-01-01

Founders:

Deepak Agrawal, Ramsey Homsany, Sri Kosuri

Number of Employees:

51-100

Last Funding Date:

2022-04-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai